Skeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen. by Posey, Karen L et al.
Matrix Pathobiology
Skeletal Abnormalities in Mice Lacking Extracellular
Matrix Proteins, Thrombospondin-1,
Thrombospondin-3, Thrombospondin-5, and Type IX
Collagen
Karen L. Posey,* Kurt Hankenson,†
Alka C. Veerisetty,* Paul Bornstein,‡ Jack Lawler,§
and Jacqueline T. Hecht*¶
From the Department of Pediatrics,* University of Texas Medical
School, Houston, Texas; the University of Pennsylvania School of
Veterinary Medicine,† Philadelphia, Pennsylvania; the
Departments of Biochemistry and Medicine,‡ University of
Washington, Seattle, Washington; the Department of Pathology,§
Beth Israel Deaconess Medical Center and Harvard Medical
School, Boston, Massachusetts; and the Shriners Hospital for
Children,¶ Houston, Texas
Thrombospondin-5 (TSP5) is a large extracellular ma-
trix glycoprotein found inmusculoskeletal tissues. TSP5
mutations cause two skeletal dysplasias, pseudoa-
chondroplasia and multiple epiphyseal dysplasia;
both show a characteristic growth plate phenotype
with retention of TSP5, type IX collagen (Col9), and
matrillin-3 in the rough endoplasmic reticulum.
Whereas most studies focus on defining the disease
process, few functional studies have been performed.
TSP5 knockout mice have no obvious skeletal abnor-
malities, suggesting that TSP5 is not essential in the
growth plate and/or that other TSPs may compensate.
In contrast, Col9 knockout mice have diminished ma-
trillin-3 levels in the extracellular matrix and early-
onset osteoarthritis. To define the roles of TSP1,
TSP3, TSP5, and Col9 in the growth plate, all knock-
out and combinatorial strains were analyzed using
histomorphometric techniques. While significant al-
terations in growth plate organization were found in
certain single knockout mouse strains, skeletal growth
was only mildly disturbed. In contrast, dramatic changes
in growth plate organization in TSP3/5/Col9 knockout
mice resulted in a 20% reduction in limb length, corre-
sponding to similar short stature inhumans. These studies
show that type IX collagen may regulate growth plate
width; TSP3, TSP5, and Col9 appear to contribute to
growth plate organization; and TSP1 may help define the
timing of growth plate closure when other extracellular
proteins are absent. (Am J Pathol 2008, 172:1664–1674;
DOI: 10.2353/ajpath.2008.071094)
Thrombospondin-5 (TSP5), also known as cartilage oli-
gomeric matrix protein, is the fifth member of the TSP
gene family that includes trimeric (TSP1 and TSP2) and
pentameric (TSP3, TSP4, and TSP5) protein members.1
First identified in cartilage and considered to be cartilage
specific, TSP5 was subsequently found in other muscu-
loskeletal tissues and is used as a marker for osteoarthri-
tis and joint injury.2–9 TSP5 has been intensely studied,
because mutations in this gene were shown to cause
pseudoachondroplasia and multiple epiphyseal dyspla-
sia (MED/EDM1).10–17 Mutations result in a dominant-
negative effect on TSP5 causing massive retention of
mutant TSP5 and other extracellular matrix (ECM) pro-
teins, including types II and IX collagen and matrillin-3
(MATN3), in large rough endoplasmic reticulum cis-ter-
nae.15,18–20 Recent studies show that these ECM pro-
teins associate with TSP5 to form a structured intracellu-
lar matrix network.20 Interestingly, mutations in MATN3
(MED/EDM5) and all three type IX collagen (Col9) genes
also cause MED phenotypes (MED/EDM2, -3, and -6) that
are typically milder than the MED condition caused by
TSP5 mutations.21
Different approaches have attempted to define the role
of TSP5. Recent work suggests that TSP5 stimulates
chondrocyte proliferation through the binding of granulin-
epithelin precursor, an autocrine growth factor.22 Binding
experiments demonstrate that TSP5 interacts with types I,
II and IX collagens, MATN3, aggrecan, granulin-epithelin
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precursor, and integrins.22–28 The presence of an or-
dered intracellular matrix network in pseudoachondropla-
sia chondrocytes and colocalization of these proteins in
the normal ECM suggest that TSP5 has a significant role
in the ECM.20 These observations support a model in
which TSP5, type IX collagen, and MATN3 interact and
function to establish and maintain the homeostasis of the
ECM.29 Furthermore, TSP1 and TSP3 are present in the
growth plate and may play similar and/or redundant roles
with TSP5 in ECM.
TSP1, TSP3, TSP5, and type IX collagen knockout mice
were previously evaluated in other studies.30–34 Interest-
ingly, loss of type IX collagen, TSP1, TSP3, TSP5, or
MATN3 reportedly causes minor or no overt phenotypic
changes, and life spans were normal. Type IX collagen
knockout mice have early-onset osteoarthritis, suggest-
ing that the loss of this protein affects matrix integrity and
permits articular cartilage erosion.31 TSP1- and TSP2-null
mice have wound-healing abnormalities30 and minor
craniofacial dysmorphism,35 whereas TSP3 knockout
mice show accelerated endochondrial ossification and
increased trabecular bone in the femoral head.32,36
The MATN3 knockout mouse has higher bone mineral
density and increased prevalence of arthritis.37 In con-
trast, TSP5 knockout mice show no reported pheno-
typic abnormalities.33
The TSP genes have been implicated in different dis-
ease processes, not limited to the growth plate. TSP3 is
highly expressed in osteosarcomas and associated with
metastasis.38,39 Single nucleotide polymorphic variants
in TSP2 and TSP4 are associated with early-onset coro-
nary disease,40 with the TSP4 A387P variant specifically
associated with atherosclerosis.41 Only TSP5 mutations
have been found to cause defined disease pathology,
whereas variation in the other TSP genes contributes to
the development of complex human disorders.39–42
In this study, growth plates from single and combi-
natorial knockout mouse strains were systematically
evaluated to elucidate the roles of type IX collagen and
TSP1, TSP3, and TSP5 in the growth plate. We show that
the loss of individual proteins affects growth plate size and
organization, whereas compound loss exacerbates growth
plate disorganization and causes short limb length.
Materials and Methods
Knockout Mice
Four previously described knockout mouse lines, TSP1,
TSP3, TSP5, and Col IX, were evaluated.30–34 Controls
and compound knockout strains, TSP5/Col9, TSP3/5,
TSP1/3/5, TSP3/5/Col9, TSP1/5/Col9, and TSP1/3/5/Col9,
were generated and are shown in Table 1. Because the
genetic background was not the same for all strains,
controls were bred for each strain. Genotyping primers
specific for each knockout strain are shown in Table 2 as
is the original reference describing the knockout strain.
Histology and Immunohistochemistry
Hind limbs from control and knockout mice were ob-
tained from 1- and 2-month-old mice, and the growth
plate from upper tibias were analyzed in all studies. The
limbs were fixed in Carson Millonig, pH 7.4 (10% forma-
lin), or ethanol, and decalcified for 1 week in Immunocal
formic acid decalcifier solution (American Master Tech
Scientific, Inc., Lodi, CA). After embedding in paraffin,
5-m sections were stained with H&E, following standard
protocols.
For immunohistochemistry, the sections were digested
with 1 mg/ml pepsin A (Sigma-Aldrich, St. Louis, MO) in
0.1 N HCl for 30 minutes at room temperature for all
antibodies except type X collagen. Sections for type X
collagen staining were digested in 1 mg/ml hyaluroni-
Table 1. Mouse Knockout Strains Used and Control
Background Strains
Strain Background
TSP1 C57BL/6
Col9
TSP3 129SvJ
TSP5 129SvJ  C57BL/6
TSP3/5
TSP5/Col9 (129SvJ  C57BL/6)  C57BL/6
TSP1/3/5
TSP1/5/Col9
TSP3/5/Col9
TSP1/3/5/Col9
Table 2. Genotype Primer Sequences
Strain Primer Reference
Tsp1 5-GAGTTTGCTTGTGGTGAACGCTCAG-3 Agah et al30
5-AGGGCTATGTGGAATTAATATCGG-3
5-TGCTGTCCATCTGCACGAGACTAG-3
Tsp3 5-CTGTGGCAGAGAAGATTCGGA-3 Hankenson et al32
5-ATCGTGTGTTGTCTTGGCGAG-3
5-GTGGATGTGGAATGTGTGCGA-3
Tsp5 5-TTGCTCGTTAGGGACTCCAT-3 Svensson et al33
5-CAGAAGCAAAGGTCGTGGAA-3
5-CGCCTTCTTGACGAGTTCTT-3
Col9 5-CCAGTGAACTCCCCTTCCATT-3 Nakata et al43
5-CTGGCCCTTTCTAACAACTCA-3
5-GATCTCCTGTCATCTCACCT-3
5-AGAACTCGTCAAGAAGGCGA-3
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dase in PBS containing 0.05% Tween 20 for 1 hour at
room temperature. The sections were rinsed in distilled
H2O and then washed in PBS containing 0.05% Tween 20
for 5 minutes, followed by 20 minutes incubation with
10% donkey serum in PBS containing 0.05% Tween 20 to
reduce nonspecific antibody binding. All sections were
then incubated overnight at 4°C with the primary anti-
body. An affinity-purified goat polyclonal MATN3 anti-
body was used at 1:500 (R&D Systems, Minneapolis,
MN) and goat polyclonal type II collagen antibody at
1:200. Affinity-purified donkey anti-goat biotin-conju-
gated secondary antibody (Chemicon International, Te-
mecula, CA) was used at a dilution of 1:500 (for MATN3)
or 1:300 (for type II collagen) for 30 minutes, followed by
horseradish peroxidase-conjugated streptavidin (Chemi-
con International) for 30 minutes. The results were de-
tected using 3.3 diaminobenzidine (Sigma-Aldrich). A
polyclonal rabbit primary TSP5 antibody was used at a
1:200 dilution (Kamiya Biomedical Co., Thousand Oaks,
CA), and rabbit polyclonal type X collagen antibody was
used at 1:200 (gift from Dr. Lunstrum, Shriners Hospital
for Children, Portland, OR). Affinity-purified donkey anti-
rabbit biotin-conjugated secondary antibody (Chemicon
International) was used at a dilution of 1:400 (for both
TSP5 and type X collagen) for 30 minutes, followed by
horseradish peroxidase-conjugated streptavidin (Chemi-
con International) for 30 minutes. The results were also
detected using 3.3 diaminobenzidine (Sigma-Aldrich).
For type IX collagen staining, a mouse monoclonal at
1:150 (Hybridoma bank at the University of Iowa) was
incubated with sections overnight and detected using the
Histomouse kit (Zymed Laboratories, South San Fran-
cisco, CA). All sections were examined, and images were
captured using an Olympus BX51 light microscope
(Olympus, Melville, NY) attached to a Spot RT camera
Ver 4.6.4.2.
Growth Plate Analysis
To control for any possible strain differences, all growth
plates from each strain were compared with their respec-
tive control background strain listed in Table 1. Upper
tibial growth plates were obtained from at least three
different mice of each strain. Growth plate organization
was blindly assessed using the following methods. Sec-
tions were examined at 100 magnification, and cells
were designated as being arranged in columns or clus-
ters using Image Pro (Media Cybernetics, Silver Spring,
MD). Lone cells or cells arranged in small groups were
classified as clustered to differentiate them from cells
organized in columns (see Figure 2A). The growth plate
was digitally outlined at 40 magnification, and the area
was computed using Image Pro. Measurements of the
area were calibrated using a microscopic grid. Chondro-
cyte density in the growth plate was calculated by divid-
ing the total number of chondrocytes by the area of the
growth plate per 100 m2. The chondrocyte density and
counts were averaged from at least three sections from
different limbs from each strain and their respective con-
trols. Similarly, five measurements spaced along the
width of the growth plate were taken from three sections
of different limbs using Image Pro software, and the
measurements were then averaged (see Figure 3A).
Limb Length Measurements
Soft tissue was removed from hind limb, and the resulting
skeletal tissue was fixed in 70% ethanol and then sub-
jected to radiographical examination. All limbs were at-
tached to a grid to ensure consistency and accuracy of
measurements, and at least 10 hind limbs were mea-
sured for each strain. Measurements were made from
end-to-end of both long bones in the hind limb (see
example in Figure 4A, below) using Image Pro software.
The measurements were converted to millimeters by
measuring an object of known length and calculating the
pixel-to-millimeter ratio.
Exercise Protocol
Two to four male mice from TSP5, Col9, and TSP5/Col9
knockout strains and the controls were subjected to an
exercise protocol in which they were allowed to run from
age 6 weeks to 5 months. The rodent wheel was held in
place by a heavy metal plate, and the distance run by
each mouse was recorded using a VDO C10 magnetic
bicycle monitor (Cytec, Rohrbach, Germany). Daily dis-
tances were recorded both manually and digitally from
Monday through Friday, and distance traveled on Satur-
day and Sunday was recorded with the digital monitor
only. All housing conditions and experiments were con-
ducted in compliance with University of Texas Medical
School at Houston animal care standards (protocol no.
02-022 and 05-020).
Results
Growth Plate Abnormalities
These experiments were performed to assess the roles of
TSP1, TSP3, and TSP5, and type IX collagen in the
growth plate. We first asked whether the loss of one or
more of these extracellular proteins affected develop-
ment and longevity. All offspring were liveborn, prema-
ture death was not observed, and there was no deviation
from Mendelian expectations.
We next investigated what effect the loss of individual
TSP proteins and type IX collagen had on growth plate
organization and size. We evaluated the growth plates at
1 and 2 months of age because these time spans repre-
sent periods of rapid growth, after which the mouse
growth plate is essentially quiescent and limb growth
ceases. Chondrocyte growth plate disorganization was
observed in all of the individual knockout strains at both
ages with the least effect seen in the TSP1 strain (Figure
1A). In general, the columnar patterning was disrupted,
and there was more clustering of chondrocytes. The
TSP3/5-null growth plate was similar to those of the TSP3-
and TSP5-null mice at 1 month (Figure 1A, panels E, L, G,
and N, and 1B, panels B and F). More disorganization
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was observed in the TSP5/Col9 knockout growth plate
(Figure 1B, panels, D and H) compared with either null
strain alone (Figure 1A, panels B, I, G, and N). The most
dramatic disorganization was observed in the TSP3/5/
Col9 knockout growth plate (Figure 1C, panels D and I).
This disorganization is similar to that observed when
1-integrin is inactivated in chondrocytes, resulting in
chondrocyte rotation.44 The additional loss of TSP1 with
Figure 1. Growth plates from single and compound knockout mice. A: H&E-stained upper tibial growth plates from single and compound knockout mice at 1 and 2
months of age are shown. Control growth plates (A, D, F, H, K, and M) are on the left for each strain. The loss of type IX collagen (B and I), TSP3 (E and L), or TSP5
(G and N) causes disturbance of growth plate organization. The Col9 growth plate appears wider and the chondrocytes columns are not as well defined as in the control
growth plates. Loss of TSP5 (G and N) causes minor disruption of columnar patterning, whereas loss of TSP1 (C and J) has little effect. B: Control growth plates (A, C,
E, and G) are on the left for each strain. The double knockout of TSP5/Col9 genes (D and H) produces growth plate pathology that is similar to that of the single Col9
knockout growth plate [A (B and I)], but loss of TSP3/5 (B and F) causes more growth plate disorganization than TSP5 alone [A (G and N)]. C: Control growth plates
(A and F) are on the left. Loss of TSP1/3/5 (B and G) is similar to the TSP3/5 knockout growth plate [B (B and F)] but loss of type IX collagen in combination with loss
of TSP3/5 (D and I) and TSP1/3/5 (E and J) has a significant impact on the organization of the growth plate and the hypertrophic zone. Loss of type IX collagen in
combination with loss of TSP1/5 is shown in C and H. Scale bar  100 mol/L [A (A)]. Upper tibial growth plates were used in all studies.
Growth Plate Abnormalities in ECM Knockout Mice 1667
AJP June 2008, Vol. 172, No. 6
any of the other combinations did not appear to contrib-
ute to chondrocyte disorganization (Figure 1).
The organization of the chondrocytes in the growth
plate was quantified by measuring the number of chon-
drocytes in columns or clusters. At 1 and 2 months, the
controls had 65 to 85% of the chondrocytes in columns,
compared with the knockout strains, which had 10 to 42%
in columns (Figure 2). The TSP3/5/Col9 knockout had
very few chondrocytes in columns (Figures 1C, panels D
and I, and 2). These results suggest that TSP3, TSP5, and
Figure 2. Comparison of growth plate chondrocyte organization in knockout
mice and controls. A: The method used in the classification of chondrocytes
is shown and described in Materials and Methods. B: Comparison of percent
chondrocytes organized into columns in all knockout strains and respective
controls at 1 month of age. C: Comparison of percent chondrocytes orga-
nized into columns in all knockout strains and respective controls at 2
months of age. Black and gray bars are measurements for controls and
strains, respectively. All knockout strains showed disrupted chondrocyte
columns, with the TSP1 knockout the least affected and the TSP3/5/Col9 and
TSP1/3/5/Col9 knockout strains the most affected. *P  0.05. Upper tibial
growth plates were used in all studies.
Figure 3. Loss of type IX collagen affects the width of growth plate. A: Mea-
surements of growth plates was performed as shown on the images and de-
scribed in Materials and Methods. PZ, proliferative zone: GP, growth plate. B:
Comparison of growth plate width at 1 month. Black and gray bars are mea-
surements for controls and strains, respectively, and the asterisk indicates a
significant difference from the control (P 0.05). The overall growth plate of the
Col9 and combinatorial knockout strains lacking Col9 tend to be wider com-
pared with the controls.C: By 2months, there is no difference in the width of the
Col9 growth plate compared with the control; however, the TSP1, TSP5, and
TSP3/5 growth plates are all more narrow than the control, whereas the growth
plates of the other combinatorial mouse strains are wider than the control. *P
0.05. Upper tibial growth plates were used in all studies.
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type IX collagen play a role in the chondrocyte organiza-
tion in the growth plate.
The widths of all of the growth plates are shown in
Figure 3. Significantly wider growth plates were observed
at 1 month in mouse strains lacking type IX collagen
(Col9, TSP5/Col9, TSP1/5/Col9, and TSP1/3/5/Col9) (Fig-
ure 3B). However, by 2 months, only the growth plates
from combinatorial knockout strains lacking type IX col-
lagen (TSP5/Col9, TSP1/5/Col9, TSP3/5/Col9, and TSP1/
3/5/Col9) remain wider (Figure 3C). These results sug-
gest that type IX collagen plays a role in determining
growth plate width. Interestingly, the growth plate of the
compound quadruple knockout, TSP1/3/5/Col9, is twice
the width of the control at 2 months (Figure 3C). Here, the
additional loss of TSP1 has a significant impact on the width
of the growth plate, suggesting that TSP1 loss, together with
loss of other ECM proteins, may interfere with growth plate
closure (Figure 1C). In contrast, the TSP3/5 growth plate is
thinner than the control at both ages, whereas this obser-
vation was made in TSP1 and TSP5 knockout growth plates
only at 2 months (Figure 3, B and C).
To assess the limb lengths in the single and compound
knockout mice, limbs were collected at 1 month, and the
long bones of the hind limbs were measured by radio-
graphical examination, as shown in Figure 4A. Loss of
type IX collagen resulted in a 5% reduction in limb length.
An 8% reduction was observed with loss of both TSP3/5.
The combinatorial knockout strains showed the most dra-
matic reductions ranging from 11 to 21%. Loss of TSP1
alone or in combination did not contribute to limb length
reduction (Figure 4B).
We next asked whether the quantity and distribution of
TSP5, types II and IX collagens, and MATN3 protein in
growth plate were altered. All sections were immunostained
simultaneously. MATN3 was diminished in type IX knockout
growth plates and in all combinatorial Col9 knockout strains
(Figure 5). MATN3 incorporation into ECM was not affected
by loss of TSP1, TSP5, and TSP3/5 (Figure 5). TSP5 staining
was mildly decreased in the Col9 knockout growth plate,
which showed limited patchy staining in the hypertrophic
zone (data not shown). These observations are consistent
with previous findings.29 No intracellular protein retention
was observed. Immunolocalization of types II and IX colla-
gens were similar in null and control mice strains.
Effect of Exercise on Articular Cartilage
Previous studies showed that 9-month-old type IX colla-
gen knockout mice develop arthritis more often than con-
trols.31 To determine whether TSP5 knockout mice were
more prone to arthritis, Col9, TSP5, and TSP5/Col9
knockout mice were subjected to exercise (Figure 6;
Table 3). The mice ran an average of 960  405 miles
(range, 277 to 1488 miles) from 6 weeks to 5 months of
age. There was no correlation between genotype and the
distance the mice ran. Compared with the control (Figure
6A), the Col9 knockout nonrunner mice had flat articular
cartilage (Figure 6D; Table 3). However, exercise further
accentuated the flattening of the articular surface (Figure
6G). The TSP5 runner had very mild flattening (Figure 6H)
compared with nonrunner and control (Figure 6, E and B)
articular cartilage (Table 3). TSP5/Col9 knockout articular
cartilage had cartilage flattening similar to Col9 single
knockout mice, but in the absence of both TSP5 and
Col9, fibrillation of the articular cartilage surface was also
observed (Figure 6, F and I). Cartilage fibrillation is a
hallmark of cartilage degeneration.45 These findings sug-
gest that a combination of TSP5 and Col9 deficiency
results in development of exercise-associated cartilage
degeneration.
Discussion
Previous observations suggest that individual loss of
TSP1, TSP3, TSP5, and type IX collagen causes modest
to no alteration in murine skeletal development.30–33,35 In
this work, we focused on the combinatorial role(s) that
TSP1, TSP3, TSP5, and type IX collagen plays in the
growth plate and on whether their functions are redun-
dant. Toward this goal, we compared several parameters
in single and combinatorial knockout mice: growth plate
Figure 4. Measurement of bone length. A: Measurement of the TSP1/3/5/
Col9 limb compared with control limb is shown and described in Materials
and Methods. B: Comparison of hind limb length from all knockout strains.
Black and gray bars are measurements for controls and strains, respectively,
and the asterisk indicates a significant difference (P  0.05) from the
control. The long bones of the hind limb are significantly shorter in Col9,
TSP3/5, TSP5/Col9, TSP1/3/5, TSP1/5/Col9, TSP3/5/Col9, and TSP1/3/5/
Col9 mice. The combinatorial loss of TSP3, TSP5, and type IX collagen has
the greatest effect on limb length. *P  0.05.
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organization, chondrocyte density, growth plate width,
and relative presence and distribution of TSP5, types II
and IX collagen, and MATN3 in the ECM.
These studies led to several novel observations. First,
a deficiency in any one of these individual proteins dis-
turbs the columnar arrangement of chondrocytes in the
growth plate, although the lack of TSP-1 only mildly per-
turbed chondrocyte organization. Increased growth plate
width was associated with loss of type IX collagen at only
1 month of age and was found in combination strains
lacking type IX collagen. In contrast, the growth plate is
significantly narrower at 1 and 2 months in the TSP3/5
knockout strain, and their hind limbs were 8% shorter
than the controls. A 20% reduction in limb length and
almost complete loss of chondrocyte columnar pattern-
ing was observed in TSP3/5/Col9 knockout mice. Taken
together, these results show that the loss of individual
ECM proteins and combinatorial loss significantly impact
growth plate organization and long bone growth.
TSP1 single- and TSP1/2 double-null mice recruit fewer
macrophages and produce less monocyte chemoattrac-
tant protein in wounds, whereas both TSP2 and TSP3
knockout mice have thicker cortical bone.30,32,36 Addi-
tionally, TSP3 knockout mice show earlier ossification and
more trabecular bone in the femoral head.32 Previous
work with these null mice focused on assessing gross
skeletal parameters, and identified subtle skeletal abnor-
malities. Here, a detailed study of growth plates and long
bones has revealed both subtle alterations in single-null
strains and more dramatic alterations in compound-null
mice. The TSP1-null growth plate shows the least disor-
ganization followed by that in TSP3-null growth plates
(Figure 2). In contrast to a previous report that TSP5
knockout mice had no growth plate abnormalities,33 us-
ing quantitative morphometry, we demonstrate significant
growth plate disorganization (Figure 3). However, none of
the single TSP knockout mice showed any reduction in
limb length, despite an abnormal growth plate organiza-
tion. This finding suggests that the individual loss of any
of these three TSP proteins is not sufficient to disrupt long
bone development or growth.
In contrast to the TSP-null mouse strains, previous
studies of type IX collagen knockout mice showed early-
onset osteoarthritis,31,43 less MATN3 incorporation into
Figure 5. Distribution of MATN3 in knockout growth plates. Growth plates were simultaneously immunostained with an antibody to MATN3, as described in
Materials and Methods. Control sections are to the left for all strains (A, D, F, H, J, and L). MATN3 was markedly diminished in the Col9 knockout growth plate
and in all compound knockout growth plate strains that do not synthesize type IX collagen (B, K, N, O, and P). Interestingly, the Col9 knockout growth plate
shows light immunostaining throughout the proliferative zone and darker staining in the hypertrophic zone (B). Loss of TSP1, TSP3, and TSP5 does not affect the
quantity or distribution of MATN3 (C, E, and G). Loss of TSP3/5 (I) and TSP1/3/5 (M) are also shown. Scale bar  100 mol/L. Upper tibial growth plates were
used in all studies.
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Figure 6. Articular cartilage from hind limbs from knockout mice subjected to exercise regimen. C0l9, TSP5, TSP5/Colp knockout, and control mice were
subjected to a running exercise regimen, as described in Materials and Methods. The H&E-stained articular cartilage sections are shown. All of the wild-type
running mice (A, B, and C) had normal articular cartilage. The nonrunner TSP5 knockout mice (E) had relatively normal articular cartilage, whereas the articular
cartilage of the runners (H) was mildly flattened. At the end of the exercise regimen, the Col9 knockout nonrunner (D) had mild flattening, whereas the runner
(G) had severe flattening (asterisk) of the articular cartilage. Interestingly, the TSP5/Col9 knockout nonrunner (F) had flattened articular cartilage (asterisk), and
exercise caused additional flattening (asterisk) and fraying (arrow) of the cartilage in the runner (I). A closer view of the articular cartilage cap is shown below
each panel (a–i). Scale bar  100 mol/L.
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the matrix,29 degraded type II collagen fibrils,46 and
slower fracture repair.47 We observed similar findings
and, in addition, found wider growth plates and signifi-
cant limb shortening at 1 month of age. Lower chondro-
cyte density was found in these mice, although the
growth plate was wider, suggesting that although there is
a similar number of chondrocytes, they are distributed
over a larger area. This may indicate that there is more
interterritorial matrix or less dense matrix because of
absent matrix proteins in these growth plates. Further-
more, the ratio of the proliferative zone to the total width of
the growth plate is similar to that of the controls, indicat-
ing that chondrocyte proliferation is not increased in
these mice (Figure 3A; data not shown). This increase in
growth plate width does not lead to longer limbs but
rather to significantly shorter hind limbs (Figure 4). These
results suggest that loss of type IX collagen has a more
significant impact, compared with loss of any of the indi-
vidual TSP proteins.
Loss of type IX collagen also affects MATN3 incorpo-
ration into the interterritorial matrix of the growth plate
(Figure 5), a finding that is consistent with previous ob-
servations.29 The loss of MATN3 immunostaining does
not obviously correlate with chondrocyte organization.
For example, when comparing control with TSP1/3/5
growth plates, no appreciable differences in MATN3 im-
munostaining are observed despite a significant differ-
ence in chondrocyte organization (Figures 5, L and M,
and 2).
MATN3 is a member of a family of proteins proposed to
be adaptor molecules that bind to the collagen net-
work,48 and it colocalizes with and binds to TSP5.27
MATN3 binds directly to type IX collagen29; therefore
decreased incorporation of MATN3 is expected in the
absence of type IX collagen. No appreciable decrease in
MATN3 immunostaining was found in the ECM of TSP5-
null mice, suggesting that the interaction between
MATN3 and TSP5 may be of lower affinity than the inter-
action between MATN3 and type IX collagen. Because
individual losses of TSP1, TSP3, TSP5, and type IX col-
lagen all cause perturbation of the growth plate, the next
set of studies was undertaken to determine whether these
ECM proteins are functionally redundant. Both TSP3 and
TSP5 proteins are expressed in the growth plate and are
pentameric members of the same gene family. Loss of
both proteins does not disturb chondrocyte organization
more than the loss of an individual protein (Figures 1 and
2) but has a significantly increased impact on growth
plate width (Figure 3) and hind limb length, which is
reduced by 8% (Figure 4). This finding suggests that
TSP3 and TSP5 do not play completely redundant or
compensatory roles. In contrast, the loss of both TSP5
and type IX collagen does not have a substantial impact
on the growth plate parameters that is more than the loss
of type IX collagen alone (Figures 1 to 3). These results
suggest that type IX collagen plays a more significant
role in the growth plate than members of the TSP family
and that the latter proteins most likely function in same
pathway.
With the exception of the TSP1/3/5-null strain, all triple-
and quadruple-null strains have approximately 10% or
less of their chondrocytes organized into columns. The
TSP3/5/Col9 knockout strain showed the most significant
growth plate disorganization and limb length reduction
(20%; Figures 1 to 4). The loss of TSP1 has a minor
impact on the organization of the growth plate and hind
limb lengths. However, the TSP1/3/5/Col9 knockout strain
has a much wider growth plate at 2 months when com-
pared with the control or the TSP3/5/Col9 strain. This
finding suggests that TSP1 could play a role in timing of
growth plate closure when other ECM proteins are absent
(Figure 3C). Whereas few hypertrophic chondrocytes are
observed in the TSP5/Col9, TSP1/5/Col9, TSP3/5/Col9,
and TSP1/3/5/Col9 strains at 1 month of age, significant
numbers are present at 2 months of age (Figure 1). Type
X collagen immunostaining was used to identify the hy-
pertrophic zone (data not shown). This observation may
be indicative of delay in chondrocyte maturation, despite
the presence of TSP1 in some of the strains. Altogether,
these observations suggest a role for TSP1 in the regu-
lation of growth plate closure and a role for TSP5 and type
IX collagen in maturation of chondrocytes. These findings
are consistent with recent work showing slow cartilage
maturation and bone formation during fracture repair in
type IX collagen knockout mice.47
To evaluate the integrity of the articular cartilage ma-
trix, TSP5, Col9, and TSP5/Col9 knockout strains were
subjected to an exercise protocol from 6 weeks to 5
months of age. We found that exercise-induced flattening
of the articular cartilage superficial zone cap was most
pronounced in the hind limbs of the type IX collagen
knockout mice but was also present, to a lesser extent, in
the TSP5 knockout mice. Exercise had the most dramatic
effect on the articular cartilage of Col9 knockout mice by
exacerbating joint erosion. Interestingly, mice lacking
both type IX collagen and TSP5 have a flattened articular
cartilage even without exercise, and exercise caused
fraying of the articular cartilage surface. Osteoarthritic
changes were not observed in the wild-type mice with
exercise (Figure 6). These results suggest that both TSP5
and type IX collagen play a role in maintaining homeosta-
sis of the articular cartilage. These findings also have
implications for the human skeletal dysplasias caused by
mutations in TSP5 and type IX collagen genes that are
associated with joint erosion and early-onset osteoarthri-
tis.17,42,49 These abnormalities are likely related to dimin-
ished amounts of these proteins in the matrix.13,50,51
However, other factors, such as the presence of mutant
protein could contribute to the disease phenotype.
The results of these studies indirectly suggest different
and nonredundant roles for TSP1, TSP3, TSP5, and type
Table 3. Effects on Articular Cartilage from Hind Limbs
from Knockout Mice Subjected to Exercise
Regimen
Nonrunner Runner
Flattening Fibrillation Flattening Fibrillation
Control No No No No
Col9  No  No
TSP5 No No  No
Col9/TSP5  No  Yes
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IX collagen in the growth plate. TSP1 appears to primarily
affect the timing of growth plate closure. TSP3, TSP5, and
type IX collagen all participate in growth plate organiza-
tion that directly modulates linear growth. Additionally,
TSP5 and type IX collagen affect chondrocyte maturation
and articular cartilage homeostasis. These findings can
be extrapolated to the growth plate pathology observed
in skeletal dysplasias caused by mutations in TSP5, type
IX collagen, and MATN3 genes. These skeletal dyspla-
sias results from chondrocyte pathology related to cellu-
lar protein retention and to loss of one or more of these
proteins in the ECM. The results of this study suggest that
loss of these proteins from the matrix affects organiza-
tional regulation and may significantly contribute to the
growth plate pathology observed in pseudoachondropla-
sia and MED. In summary, we suggest that TSP3, TSP5,
and type IX collagen operate in concert and are impor-
tant for proper growth plate organization and that TSP1
functions in a minor or accessory role in the growth plate.
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